252 related articles for article (PubMed ID: 8524329)
1. Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines.
Strahl C; Blackburn EH
Mol Cell Biol; 1996 Jan; 16(1):53-65. PubMed ID: 8524329
[TBL] [Abstract][Full Text] [Related]
2. The effects of nucleoside analogs on telomerase and telomeres in Tetrahymena.
Strahl C; Blackburn EH
Nucleic Acids Res; 1994 Mar; 22(6):893-900. PubMed ID: 8152919
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of telomerase activity and cell proliferation by a reverse transcriptase inhibitor in gynaecological cancer cell lines.
Murakami J; Nagai N; Shigemasa K; Ohama K
Eur J Cancer; 1999 Jun; 35(6):1027-34. PubMed ID: 10533489
[TBL] [Abstract][Full Text] [Related]
4. Irreversible telomere shortening by 3'-azido-2',3'-dideoxythymidine (AZT) treatment.
Gomez DE; Tejera AM; Olivero OA
Biochem Biophys Res Commun; 1998 May; 246(1):107-10. PubMed ID: 9600076
[TBL] [Abstract][Full Text] [Related]
5. [Azidothymidine, blocking telomerase functioning, shortens telomeric repeats in transformed human cells].
Egorov EE; Akhmalisheva AKh; Smirnova IuB; Shinkarev DB; Chernov DN; Zelenin AV; Kraevskiĭ AA
Genetika; 1997 Oct; 33(10):1444-6. PubMed ID: 9445812
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT).
Periclou AP; Nandy P; Avramis VI
In Vivo; 2000; 14(3):377-88. PubMed ID: 10904870
[TBL] [Abstract][Full Text] [Related]
7. Cyclic induction of senescence with intermittent AZT treatment accelerates both apoptosis and telomere loss.
Ji HJ; Rha SY; Jeung HC; Yang SH; An SW; Chung HC
Breast Cancer Res Treat; 2005 Oct; 93(3):227-36. PubMed ID: 16132531
[TBL] [Abstract][Full Text] [Related]
8. 3'-Azido-2',3'-dideoxynucleoside 5'-triphosphates inhibit telomerase activity in vitro, and the corresponding nucleosides cause telomere shortening in human HL60 cells.
Liu X; Takahashi H; Harada Y; Ogawara T; Ogimura Y; Mizushina Y; Saneyoshi M; Yamaguchi T
Nucleic Acids Res; 2007; 35(21):7140-9. PubMed ID: 17942424
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effect of Carbovir, AZT, and dideoxynucleoside triphosphates on the activity of human immunodeficiency virus reverse transcriptase and selected human polymerases.
White EL; Parker WB; Macy LJ; Shaddix SC; McCaleb G; Secrist JA; Vince R; Shannon WM
Biochem Biophys Res Commun; 1989 Jun; 161(2):393-8. PubMed ID: 2472136
[TBL] [Abstract][Full Text] [Related]
10. Telomerase-inhibitory effects of the triphosphate derivatives of some biologically active nucleosides.
Yamaguchi T; Takayama Y; Saito M; Ishikawa F; Saneyoshi M
Nucleic Acids Res Suppl; 2001; (1):211-2. PubMed ID: 12836339
[TBL] [Abstract][Full Text] [Related]
11. Lack of synergy in the inhibition of HIV-1 reverse transcriptase by combinations of the 5'-triphosphates of various anti-HIV nucleoside analogs.
White EL; Parker WB; Ross LJ; Shannon WM
Antiviral Res; 1993 Dec; 22(4):295-308. PubMed ID: 7506513
[TBL] [Abstract][Full Text] [Related]
12. Telomere shortening in human HL60 cells by treatment with 3'-azido-2',3'-dideoxynucleosides and telomerase inhibition by their 5'-triphosphates.
Liu X; Inomata M; Ogawara T; Saneyoshi M; Yamaguchi T
Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):1067-71. PubMed ID: 18058538
[TBL] [Abstract][Full Text] [Related]
13. Influence of 3'-azido-2',3'-dideoxyguanosine treatment on telomere length in human telomerase-immortalized human fibroblast cells.
Kurashina Y; Liu X; Kato C; Inoue N; Saneyoshi M; Yamaguchi T
Nucleic Acids Symp Ser (Oxf); 2009; (53):249-50. PubMed ID: 19749354
[TBL] [Abstract][Full Text] [Related]
14. [Suppression of alternative telomere lengthening in cancer cells with reverse transcriptase inhibitors].
Bondarev IE; Khavinson VK
Adv Gerontol; 2016; 29(2):218-221. PubMed ID: 28514537
[TBL] [Abstract][Full Text] [Related]
15. Evidence of in vitro development of drug resistance to azidothymidine in T-lymphocytic leukemia cell lines (Jurkat E6-1/AZT-100) and in pediatric patients with HIV-1 infection.
Avramis VI; Kwock R; Solorzano MM; Gomperts E
J Acquir Immune Defic Syndr (1988); 1993 Dec; 6(12):1287-96. PubMed ID: 8254464
[TBL] [Abstract][Full Text] [Related]
16. Telomerase inhibition using azidothymidine in the HT-29 colon cancer cell line.
Brown T; Sigurdson E; Rogatko A; Broccoli D
Ann Surg Oncol; 2003 Oct; 10(8):910-5. PubMed ID: 14527910
[TBL] [Abstract][Full Text] [Related]
17. The effects of telomerase inhibitors on lymphocyte function.
Beltz L; Moran R; Elsawy O; Sadler J; Jurgenson J
Anticancer Res; 1999; 19(4B):3205-11. PubMed ID: 10652613
[TBL] [Abstract][Full Text] [Related]
18. Reverse transcriptase inhibitors suppress telomerase function and induce senescence-like processes in cultured mouse fibroblasts.
Yegorov YE; Chernov DN; Akimov SS; Bolsheva NL; Krayevsky AA; Zelenin AV
FEBS Lett; 1996 Jul; 389(2):115-8. PubMed ID: 8766811
[TBL] [Abstract][Full Text] [Related]
19. [Telomerase activity in murine cells during spontaneous transformation].
Chernov DN; Egorov EE; Akimov SS
Dokl Akad Nauk; 1996 Jul; 349(1):121-3. PubMed ID: 8963216
[No Abstract] [Full Text] [Related]
20. Effect of telomere and telomerase interactive agents on human tumor and normal cell lines.
Rha SY; Izbicka E; Lawrence R; Davidson K; Sun D; Moyer MP; Roodman GD; Hurley L; Von Hoff D
Clin Cancer Res; 2000 Mar; 6(3):987-93. PubMed ID: 10741725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
